Skip to the page

Data / Drug companies / Acetazolamide

Acetazolamide: 37 companies and 69 products in the FDA NDC directory

Acetazolamide is listed in the FDA National Drug Code Directory by 37 companies, with 69 products in commercial distribution. 69 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, extended release; injection, powder, lyophilized, for solution, and the newest product started marketing on April 28, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
37
Products
69
Generic (ANDA) products
69 (100.0%)
Application numbers
21
Routes
Oral, Intravenous
openFDA record search
api.fda.gov

Companies that list acetazolamide

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.5tablet; injection, powder, lyophilized, for solutionGeneric drugs (ANDA)November 15, 2022
A-S Medication Solutions4tablet; capsule, extended releaseGeneric drugs (ANDA)July 15, 2023
Chartwell RX, LLC3tablet; capsule, extended releaseGeneric drugs (ANDA)February 15, 2021
NuCare Pharmaceuticals,Inc.3tabletGeneric drugs (ANDA)July 15, 2023
PD-Rx Pharmaceuticals, Inc.3tabletGeneric drugs (ANDA)January 30, 2020
Zydus Pharmaceuticals USA Inc.3tablet; capsuleGeneric drugs (ANDA)August 4, 2023
Aarkish Pharmaceuticals NJ Inc.2tabletGeneric drugs (ANDA)December 3, 2024
Advagen Pharma Ltd2tabletGeneric drugs (ANDA)August 19, 2021
Ajanta Pharma USA Inc.2tabletGeneric drugs (ANDA)September 11, 2023
Ani Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)October 17, 2019
Aurobindo Pharma Limited2tabletGeneric drugs (ANDA)May 30, 2025
AvKARE2tabletGeneric drugs (ANDA)May 18, 2017
Bryant Ranch Prepack2tabletGeneric drugs (ANDA)November 13, 2020
Bryant Ranch Prepack2tabletGeneric drugs (ANDA)November 13, 2020
Bryant Ranch Prepack2tablet; capsule, extended releaseGeneric drugs (ANDA)November 19, 2021
Eywa Pharma Inc2tabletGeneric drugs (ANDA)January 30, 2020
Hikma Pharmaceuticals USA Inc.2injection, powder, lyophilized, for solutionGeneric drugs (ANDA)May 1, 1996
Lifestar Pharma LLC2tabletGeneric drugs (ANDA)November 13, 2020
Marlex Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)February 1, 2026
Strides Pharma Science Limited2tabletGeneric drugs (ANDA)November 20, 2017
TruPharma, LLC2tabletGeneric drugs (ANDA)April 19, 2021
Viona Pharmaceuticals Inc2tabletGeneric drugs (ANDA)July 15, 2023
Zydus Lifesciences Limited2tabletGeneric drugs (ANDA)July 15, 2023
Accord Healthcare Inc.1capsule, extended releaseGeneric drugs (ANDA)November 19, 2021
Alembic Pharmaceuticals Inc.1capsule, extended releaseGeneric drugs (ANDA)February 20, 2019
Alembic Pharmaceuticals Limited1capsule, extended releaseGeneric drugs (ANDA)February 20, 2019
American Health Packaging1capsuleGeneric drugs (ANDA)October 27, 2020
AvPAK1tabletGeneric drugs (ANDA)July 7, 2020
Gland Pharma Limited1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)June 17, 2025
Ingenus Pharmaceuticals, LLC1capsule, extended releaseGeneric drugs (ANDA)July 31, 2017
Major Pharmaceuticals1tabletGeneric drugs (ANDA)March 15, 2013
Northwind Health Company, LLC1tabletGeneric drugs (ANDA)March 28, 2023
Proficient Rx LP1tabletGeneric drugs (ANDA)November 21, 2017
Remedyrepack Inc.1capsule, extended releaseGeneric drugs (ANDA)April 28, 2026
Westminster Pharmaceuticals, LLC1capsule, extended releaseGeneric drugs (ANDA)April 20, 2023
XGen Pharmaceuticals DJB, Inc.1injection, powder, lyophilized, for solutionGeneric drugs (ANDA)December 10, 2008
Zydus Lifesciences Limited1capsuleGeneric drugs (ANDA)April 10, 2019

Dosage forms

Dosage formProductsShare
Tablet5072.5%
Capsule, extended release1014.5%
Injection, powder, lyophilized, for solution68.7%
Capsule34.3%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)69100%

Pharmacologic classes

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.